PharmiWeb2h
Quest International Achieves ANSI/ESD Certification for German Facility, Strengthening International Depot Repair Services and Capabilities
The Certification Joins Quest's 4 Existing ISO Registrations to Form the Industry's Most Complete Quality Management System IRVINE, CALIFORNIA / ACCESSWIRE / January 9, 2025 / Quest International, the ...
PharmiWeb8h
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...
PharmiWeb4h
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
PharmiWeb4h
Med-X Partners with Anasac Ambiental for Nature-Cide Product Distribution in South America
Exclusive Distributor to Drive International Growth in Chile, Argentina, Peru and Colombia LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / Med-X, Inc., a leading innovator of all-natural green scene ...
PharmiWeb4h
UniDoc - Company Recognizes Initial Revenue on Delivery of AI-Equipped H3 Health Cubes
Three customers take delivery at year endVANCOUVER, BC / ACCESSWIRE / January 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth ...
PharmiWeb4h
Nanomerics Reports Complete Dosing of the Last Volunteer in the OC134 SUNLIGHT Trial
LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it had completed 28 consecutive days of administration in its OC134 Phase ...
PharmiWeb3h
Formycon included in TecDAX Index of Deutsche Börse
MiscellaneousFormycon included in TecDAX Index of Deutsche Börse 09.01.2025 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // January 9, ...
PharmiWeb4h
Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services
SIOUX FALLS, SD / ACCESSWIRE / January 9, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, is proud to announce the acquisition of Amwell Psychiatric ...
PharmiWeb4h
CliniOps Announces Strategic Partnership With Indegene to Accelerate Clinical Trials
Offers an end-to-end platform for patient recruitment, data management, Biostatistics and regulatory submission FREMONT, CALIFORNIA / ACCESSWIRE / January 9, 2025 / CliniOps, Inc., a leading provider ...
PharmiWeb3h
Laxxon Medical Announces Appointment of Two New Members to Board of Directors
New independent directors Christof Bircher and Nneka Ukpai bring significant expertise in business strategy, corporate finance and technology development to Laxxon's Board of Directors. NEW YORK, NY / ...
PharmiWeb7h
Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS
Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces it has entered a ...
PharmiWeb7h
New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...